GVHD

Leah SherwoodTransplantation & Cellular Therapy | November 22, 2022
Nearly a third of patients with chronic graft-versus-host disease (GVHD) were able to discontinue long-term systemic therapy ...
Advertisement
Advertisement
Advertisement
Advertisement